TipRanks
Advertisement
Advertisement
Cambium Bio Plans Issue of 2 Million Options in ASX Placement
PremiumCompany AnnouncementsCambium Bio Plans Issue of 2 Million Options in ASX Placement
19d ago
Cambium Bio Files Updated Corporate Governance Statement and Appendix 4G
Premium
Company Announcements
Cambium Bio Files Updated Corporate Governance Statement and Appendix 4G
23d ago
Cambium Bio Narrows Annual Loss as Asset Backing Improves
Premium
Company Announcements
Cambium Bio Narrows Annual Loss as Asset Backing Improves
23d ago
Regeneus Rectifies Late Substantial Shareholder Disclosure for Cambium Holdings
PremiumCompany AnnouncementsRegeneus Rectifies Late Substantial Shareholder Disclosure for Cambium Holdings
3M ago
Regeneus Rectifies Late Substantial Shareholder Notice Filing
Premium
Company Announcements
Regeneus Rectifies Late Substantial Shareholder Notice Filing
3M ago
Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular
Premium
Company Announcements
Cambium Bio Wins FDA Backing for Single Pivotal Trial for Elate Ocular
5M ago
Cambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows
PremiumCompany AnnouncementsCambium Bio Narrows Half-Year Loss and Turns NTAs Positive as Revenue Grows
7M ago
Cambium Bio Plans Significant Share Placement to Raise Equity
Premium
Company Announcements
Cambium Bio Plans Significant Share Placement to Raise Equity
7M ago
Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control
Premium
Company Announcements
Cambium Bio Calls Vote on Share Placement to Boost Major Holder’s Control
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100